Telavancin Observational Use Registry (TOUR)

Clinical trial NCT02288234 · COMPLETED

Trial details

NCT number: NCT02288234
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Hospital Acquired Bacterial Pneumonia Complicated Skin and Skin Structure Infections Ventilator Associated Bacterial Pneumonia Gram Positive Infection

Start date: 2014-11-01
Primary completion: 2017-06-01
Enrollment: 1063

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.